Logo image of CBGB.DE

CARLSBERG AS-B (CBGB.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:CBGB - DK0010181759 - Common Stock

105.65 EUR
-0.3 (-0.28%)
Last: 11/26/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, CBGB scores 3 out of 10 in our fundamental rating. CBGB was compared to 27 industry peers in the Beverages industry. CBGB has a medium profitability rating, but doesn't score so well on its financial health evaluation. CBGB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CBGB had positive earnings in the past year.
In the past year CBGB had a positive cash flow from operations.
In multiple years CBGB reported negative net income over the last 5 years.
CBGB had a positive operating cash flow in each of the past 5 years.
CBGB.DE Yearly Net Income VS EBIT VS OCF VS FCFCBGB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B -20B -30B -40B

1.2 Ratios

The Return On Assets of CBGB (5.78%) is better than 85.19% of its industry peers.
The Return On Equity of CBGB (35.73%) is better than 88.89% of its industry peers.
With an excellent Return On Invested Capital value of 8.91%, CBGB belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBGB is significantly above the industry average of 7.71%.
Industry RankSector Rank
ROA 5.78%
ROE 35.73%
ROIC 8.91%
ROA(3y)-9.78%
ROA(5y)-3.77%
ROE(3y)-48.69%
ROE(5y)-23.03%
ROIC(3y)12.89%
ROIC(5y)11.3%
CBGB.DE Yearly ROA, ROE, ROICCBGB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

CBGB has a Profit Margin of 10.89%. This is comparable to the rest of the industry: CBGB outperforms 59.26% of its industry peers.
CBGB's Profit Margin has improved in the last couple of years.
The Operating Margin of CBGB (14.12%) is comparable to the rest of the industry.
CBGB's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 45.73%, CBGB is in line with its industry, outperforming 48.15% of the companies in the same industry.
In the last couple of years the Gross Margin of CBGB has declined.
Industry RankSector Rank
OM 14.12%
PM (TTM) 10.89%
GM 45.73%
OM growth 3Y-4.19%
OM growth 5Y-1.39%
PM growth 3Y2.18%
PM growth 5Y4.04%
GM growth 3Y-1.21%
GM growth 5Y-1.54%
CBGB.DE Yearly Profit, Operating, Gross MarginsCBGB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBGB is creating value.
CBGB has less shares outstanding than it did 1 year ago.
CBGB has less shares outstanding than it did 5 years ago.
CBGB has a better debt/assets ratio than last year.
CBGB.DE Yearly Shares OutstandingCBGB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CBGB.DE Yearly Total Debt VS Total AssetsCBGB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

Based on the Altman-Z score of 1.38, we must say that CBGB is in the distress zone and has some risk of bankruptcy.
CBGB's Altman-Z score of 1.38 is on the low side compared to the rest of the industry. CBGB is outperformed by 74.07% of its industry peers.
CBGB has a debt to FCF ratio of 14.04. This is a negative value and a sign of low solvency as CBGB would need 14.04 years to pay back of all of its debts.
CBGB has a worse Debt to FCF ratio (14.04) than 70.37% of its industry peers.
CBGB has a Debt/Equity ratio of 2.67. This is a high value indicating a heavy dependency on external financing.
CBGB has a Debt to Equity ratio of 2.67. This is amonst the worse of the industry: CBGB underperforms 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF 14.04
Altman-Z 1.38
ROIC/WACC2.3
WACC3.88%
CBGB.DE Yearly LT Debt VS Equity VS FCFCBGB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

CBGB has a Current Ratio of 0.70. This is a bad value and indicates that CBGB is not financially healthy enough and could expect problems in meeting its short term obligations.
CBGB has a Current ratio of 0.70. This is amonst the worse of the industry: CBGB underperforms 81.48% of its industry peers.
CBGB has a Quick Ratio of 0.70. This is a bad value and indicates that CBGB is not financially healthy enough and could expect problems in meeting its short term obligations.
CBGB has a Quick ratio of 0.54. This is comparable to the rest of the industry: CBGB outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.54
CBGB.DE Yearly Current Assets VS Current LiabilitesCBGB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

3. Growth

3.1 Past

The earnings per share for CBGB have decreased strongly by -26.75% in the last year.
The Earnings Per Share has been decreasing by -9.93% on average over the past years.
EPS 1Y (TTM)-26.75%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 8.50% on average over the next years. This is quite good.
CBGB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.86% yearly.
EPS Next Y7.55%
EPS Next 2Y11.68%
EPS Next 3Y10.06%
EPS Next 5Y8.5%
Revenue Next Year-2.58%
Revenue Next 2Y-2.06%
Revenue Next 3Y-1.48%
Revenue Next 5Y-1.86%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CBGB.DE Yearly Revenue VS EstimatesCBGB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B 100B
CBGB.DE Yearly EPS VS EstimatesCBGB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20 40 60 80

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.93, which means the current valuation is very expensive for CBGB.
Compared to the rest of the industry, the Price/Earnings ratio of CBGB indicates a slightly more expensive valuation: CBGB is more expensive than 70.37% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.15, CBGB is valued at the same level.
Based on the Price/Forward Earnings ratio of 23.97, the valuation of CBGB can be described as rather expensive.
81.48% of the companies in the same industry are cheaper than CBGB, based on the Price/Forward Earnings ratio.
CBGB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.93
Fwd PE 23.97
CBGB.DE Price Earnings VS Forward Price EarningsCBGB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CBGB.
CBGB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.84
EV/EBITDA 10.24
CBGB.DE Per share dataCBGB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CBGB does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CBGB may justify a higher PE ratio.
PEG (NY)3.96
PEG (5Y)N/A
EPS Next 2Y11.68%
EPS Next 3Y10.06%

6

5. Dividend

5.1 Amount

CBGB has a Yearly Dividend Yield of 3.52%.
Compared to an average industry Dividend Yield of 3.07, CBGB pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, CBGB pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.52%

5.2 History

The dividend of CBGB is nicely growing with an annual growth rate of 8.19%!
Dividend Growth(5Y)8.19%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

39.92% of the earnings are spent on dividend by CBGB. This is a low number and sustainable payout ratio.
CBGB's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP39.92%
EPS Next 2Y11.68%
EPS Next 3Y10.06%
CBGB.DE Yearly Income VS Free CF VS DividendCBGB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10B -20B -30B -40B
CBGB.DE Dividend Payout.CBGB.DE Dividend Payout, showing the Payout Ratio.CBGB.DE Dividend Payout.PayoutRetained Earnings

CARLSBERG AS-B

FRA:CBGB (11/26/2025, 7:00:00 PM)

105.65

-0.3 (-0.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-30 2025-10-30
Earnings (Next)02-04 2026-02-04/amc
Inst Owners49.32%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap14.02B
Revenue(TTM)65.35B
Net Income(TTM)8.94B
Analysts77.24
Price Target133.99 (26.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.52%
Yearly Dividend3.62
Dividend Growth(5Y)8.19%
DP39.92%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.93
Fwd PE 23.97
P/S 1.28
P/FCF 19.84
P/OCF 9.75
P/B 4.18
P/tB N/A
EV/EBITDA 10.24
EPS(TTM)3.53
EY3.34%
EPS(NY)4.41
Fwd EY4.17%
FCF(TTM)5.33
FCFY5.04%
OCF(TTM)10.84
OCFY10.26%
SpS82.86
BVpS25.25
TBVpS-56.54
PEG (NY)3.96
PEG (5Y)N/A
Graham Number44.79
Profitability
Industry RankSector Rank
ROA 5.78%
ROE 35.73%
ROCE 11.05%
ROIC 8.91%
ROICexc 9.86%
ROICexgc 67.7%
OM 14.12%
PM (TTM) 10.89%
GM 45.73%
FCFM 6.43%
ROA(3y)-9.78%
ROA(5y)-3.77%
ROE(3y)-48.69%
ROE(5y)-23.03%
ROIC(3y)12.89%
ROIC(5y)11.3%
ROICexc(3y)15.76%
ROICexc(5y)13.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.98%
ROCE(5y)14.01%
ROICexgc growth 3Y27.92%
ROICexgc growth 5Y36.11%
ROICexc growth 3Y13.8%
ROICexc growth 5Y10.01%
OM growth 3Y-4.19%
OM growth 5Y-1.39%
PM growth 3Y2.18%
PM growth 5Y4.04%
GM growth 3Y-1.21%
GM growth 5Y-1.54%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 2.67
Debt/FCF 14.04
Debt/EBITDA 4.07
Cap/Depr 113.41%
Cap/Sales 6.66%
Interest Coverage 8.51
Cash Conversion 65.44%
Profit Quality 59.02%
Current Ratio 0.7
Quick Ratio 0.54
Altman-Z 1.38
F-Score7
WACC3.88%
ROIC/WACC2.3
Cap/Depr(3y)105.07%
Cap/Depr(5y)101.51%
Cap/Sales(3y)6.06%
Cap/Sales(5y)6.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.75%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y7.55%
EPS Next 2Y11.68%
EPS Next 3Y10.06%
EPS Next 5Y8.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-2.58%
Revenue Next 2Y-2.06%
Revenue Next 3Y-1.48%
Revenue Next 5Y-1.86%
EBIT growth 1Y9.83%
EBIT growth 3Y3.16%
EBIT growth 5Y1.2%
EBIT Next Year67.33%
EBIT Next 3Y23.65%
EBIT Next 5Y17.39%
FCF growth 1Y-18.48%
FCF growth 3Y-9.14%
FCF growth 5Y-3.87%
OCF growth 1Y0.6%
OCF growth 3Y-2.69%
OCF growth 5Y-1.56%

CARLSBERG AS-B / CBGB.DE FAQ

What is the fundamental rating for CBGB stock?

ChartMill assigns a fundamental rating of 3 / 10 to CBGB.DE.


What is the valuation status for CBGB stock?

ChartMill assigns a valuation rating of 2 / 10 to CARLSBERG AS-B (CBGB.DE). This can be considered as Overvalued.


What is the profitability of CBGB stock?

CARLSBERG AS-B (CBGB.DE) has a profitability rating of 6 / 10.


How financially healthy is CARLSBERG AS-B?

The financial health rating of CARLSBERG AS-B (CBGB.DE) is 2 / 10.


Can you provide the expected EPS growth for CBGB stock?

The Earnings per Share (EPS) of CARLSBERG AS-B (CBGB.DE) is expected to grow by 7.55% in the next year.